A 4-month randomized controlled multicenter trial (DEKAN Study)
For instance, obese individuals experienced an increase in food intake by 18.3 5.3% at a low dose and 32.8 8.7% at a high dose compared to placebo
A.KashianD
(7) BPC-157 Peptide and Tissue Damage A study was conducted to understand the extent of the angiogenic potential of the peptide beyond local wounds, ligaments, and GI tract wounds and to study its action on multiple gastrointestinal lesions on the pancreas, liver injuries, heart damage, endothelium damage, and blood pressure
It may also help address symptoms such as fatigue, cognitive decline, and oxidative stress.This product is unique in the marketplace because of its acetylation, which makes it more stable in the blood and increases its ability to penetrate cells
[PMID: 9565242] PubMed record related to this compound for laboratory literature review